Ocular pharmacokinetics profile of different hydrocortisone ophthalmic formulations

被引：0
|
作者：
Bucolo, C. [1 ]
Salomone, S. [1 ]
Piazza, C. [2 ]
Blanco, A. R. [3 ]
Drago, F. [1 ]
机构：
[1] Univ Catania, Biomed & Biotechnol Sci, Catania, Italy
[2] Unifarm, Analyt Chem, Catania, Italy
[3] Alfa Intes, Med Div, Casoria, Italy
来源：
ACTA OPHTHALMOLOGICA | 2018年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
S033
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [1] Ocular Pharmacokinetics Profile of Different Indomethacin Topical Formulations
    Bucolo, Claudio
    Melilli, Barbara
    Piazza, Cateno
    Zurria, Monia
    Drago, Filippo
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (06) : 571 - 576
  • [2] Stability and Ocular Pharmacokinetics of Celecoxib-Loaded Nanoparticles Topical Ophthalmic Formulations
    Ibrahim, Mohammed Mostafa
    Abd-Elgawad, Abd-Elgawad Helmy
    Soliman, Osama Abd-Elazeem
    Jablonski, Monica M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (12) : 3691 - 3701
  • [3] Rufloxacin eyedrops: Effect of different formulations on ocular pharmacokinetics in rabbits
    Burgalassi, S
    Cappello, B
    Chetoni, P
    Iervolino, M
    Monti, D
    Saettone, MF
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2006, 16 (02) : 311 - 317
  • [4] Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease
    Bucolo, Claudio
    Fidilio, Annamaria
    Fresta, Claudia Giuseppina
    Lazzara, Francesca
    Platania, Chiara Bianca Maria
    Cantarella, Giuseppina
    Di Benedetto, Giulia
    Burgaletto, Chiara
    Bernardini, Renato
    Piazza, Cateno
    Barabino, Stefano
    Drago, Filippo
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [5] Liberation of hydrocortisone acetate from different commercial formulations
    Neubert, RHH
    Pötzsch, A
    PHARMAZIE, 2004, 59 (06): : 472 - 474
  • [6] Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species
    Jang, Mingui
    Kang, Minsung
    Lee, Eunseok
    Shin, Dongseong
    Couture, Rejean
    PHARMACEUTICALS, 2024, 17 (01)
  • [7] Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4%Ophthalmic Formulation
    Schopf L.
    Enlow E.
    Popov A.
    Bourassa J.
    Chen H.
    Ophthalmology and Therapy, 2014, 3 (1-2) : 63 - 72
  • [8] Effect of patient factors on ocular pharmacokinetics in ophthalmic drug administration
    Kunikane, Eriko
    Orii, Yusuke
    Inoue, Akiko
    Inatani, Masaru
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] PHARMACOKINETICS AND BIOEQUIVALENCE OF DIFFERENT FORMULATIONS OF AMBROXOL
    VERGIN, H
    BISHOPFREUDLING, GB
    MICZKA, M
    NITSCHE, V
    STROBEL, K
    MATZKIES, F
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1985, 35-2 (10): : 1591 - 1595
  • [10] PHARMACOKINETICS AND BIOEQUIVALENCE OF DIFFERENT FORMULATIONS OF PIRENZEPINE
    VERGIN, H
    MASCHER, H
    STROBEL, K
    NITSCHE, V
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-2 (09): : 1409 - 1412
12345